| Nome |
# |
|
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport, file e31e124d-c116-987f-e053-3705fe0a095a
|
620
|
|
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial, file e31e124e-a947-987f-e053-3705fe0a095a
|
496
|
|
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation, file e31e124d-8d6f-987f-e053-3705fe0a095a
|
461
|
|
2018 EHRA expert consensus statement on lead extraction: Recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: Endorsed by APHRS/HRS/LAHRS, file e31e124e-90c7-987f-e053-3705fe0a095a
|
414
|
|
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure, file e31e124f-9bec-987f-e053-3705fe0a095a
|
414
|
|
Effect of high-pass filtering on ECG signal on the analysis of patients prone to atrial fibrillation, file e31e124e-1411-987f-e053-3705fe0a095a
|
345
|
|
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial, file e31e124e-8393-987f-e053-3705fe0a095a
|
318
|
|
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation, file e31e124d-75fa-987f-e053-3705fe0a095a
|
239
|
|
[Implantable defibrillators and prevention of sudden death: clinical and economic implications in the light of the MADIT II study]. FT Defibrillatori impiantabili e prevenzione della morte improvvisa: implicazioni cliniche ed economiche alla luce dello studio MADIT II., file e31e124e-1aec-987f-e053-3705fe0a095a
|
229
|
|
Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples, file e31e124f-5d23-987f-e053-3705fe0a095a
|
202
|
|
Safety and efficacy of dronedarone from clinical trials to real-world evidence: Implications for its use in atrial fibrillation, file e31e124e-8002-987f-e053-3705fe0a095a
|
181
|
|
Prevalence and clinical significance of left bundle branch block according to classical or strict definition criteria in permanent pacemaker patients, file e31e124e-eaaa-987f-e053-3705fe0a095a
|
164
|
|
Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial, file e31e124e-43cc-987f-e053-3705fe0a095a
|
163
|
|
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), file e31e124e-e6ab-987f-e053-3705fe0a095a
|
159
|
|
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset, file e31e124e-71af-987f-e053-3705fe0a095a
|
156
|
|
Clinically guided pacemaker choice and setting: pacemaker expert programming study, file e31e124e-acb0-987f-e053-3705fe0a095a
|
155
|
|
Beta-blocker treatment guided by head-up tilt test in neurally mediated syncope, file e31e124e-072b-987f-e053-3705fe0a095a
|
153
|
|
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), file e31e124f-4001-987f-e053-3705fe0a095a
|
148
|
|
Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress, file e31e124d-e8bc-987f-e053-3705fe0a095a
|
146
|
|
Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD, file e31e124e-16da-987f-e053-3705fe0a095a
|
144
|
|
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary, file e31e124e-acd3-987f-e053-3705fe0a095a
|
143
|
|
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring, file e31e124d-fae9-987f-e053-3705fe0a095a
|
141
|
|
Cardiac resynchronization therapy in the real world: need to upgrade outcome research, file e31e124e-a105-987f-e053-3705fe0a095a
|
140
|
|
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS), file e31e124e-71ad-987f-e053-3705fe0a095a
|
139
|
|
Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry, file e31e124e-7c78-987f-e053-3705fe0a095a
|
134
|
|
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden, file e31e124e-b48a-987f-e053-3705fe0a095a
|
133
|
|
Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), file e31e124e-fbfb-987f-e053-3705fe0a095a
|
132
|
|
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis, file e31e124f-c98c-987f-e053-3705fe0a095a
|
132
|
|
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis, file e31e124e-dab4-987f-e053-3705fe0a095a
|
131
|
|
The empowerment of translational research: lessons from laminopathies, file e31e124e-115b-987f-e053-3705fe0a095a
|
126
|
|
Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF, file e31e124e-07f1-987f-e053-3705fe0a095a
|
124
|
|
Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden, file e31e124f-03be-987f-e053-3705fe0a095a
|
124
|
|
New left ventricular active fixation lead: The experience of lead extraction, file e31e124e-16d5-987f-e053-3705fe0a095a
|
121
|
|
Physical activity measured by implanted devices predicts atrial arrhythmias and patient outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored), file e31e124e-0a96-987f-e053-3705fe0a095a
|
120
|
|
Impact of covid-19 pandemic on remote monitoring of cardiac implantable electronic devices in italy: Results of a survey promoted by aiac (italian association of arrhythmology and cardiac pacing), file e31e124f-be41-987f-e053-3705fe0a095a
|
120
|
|
Chronic kidney disease and arrhythmias: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, file e31e124e-530a-987f-e053-3705fe0a095a
|
118
|
|
Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator, file e31e124e-e052-987f-e053-3705fe0a095a
|
117
|
|
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry, file e31e124f-9c89-987f-e053-3705fe0a095a
|
117
|
|
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase, file e31e124e-c8cc-987f-e053-3705fe0a095a
|
116
|
|
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes, file e31e124e-04d1-987f-e053-3705fe0a095a
|
115
|
|
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. Routine Practice data from the SEARCH MI registry., file e31e124e-0fa0-987f-e053-3705fe0a095a
|
114
|
|
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias, file e31e124e-ebd1-987f-e053-3705fe0a095a
|
114
|
|
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes, file e31e124e-0d19-987f-e053-3705fe0a095a
|
113
|
|
Cost-effectiveness of implantable cardioverter-defibrillator in today's world, file e31e124e-16db-987f-e053-3705fe0a095a
|
112
|
|
The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?, file e31e124e-b48f-987f-e053-3705fe0a095a
|
112
|
|
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation, file e31e124e-c8b9-987f-e053-3705fe0a095a
|
111
|
|
The wearable cardioverter-defibrillator: Current technology and evolving indications, file e31e124e-f013-987f-e053-3705fe0a095a
|
111
|
|
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study, file e31e124e-0fa1-987f-e053-3705fe0a095a
|
109
|
|
Against all odds: Targeted pacing site for resynchronization therapy by venoplasty and active fixation lead, file e31e124e-1a51-987f-e053-3705fe0a095a
|
109
|
|
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation, file e31e124e-aca9-987f-e053-3705fe0a095a
|
109
|
|
Device-detected subclinical atrial tachyarrhythmias: Definition, implications and management - An European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), file e31e124e-e6e0-987f-e053-3705fe0a095a
|
106
|
|
Pacemaker-detected severe sleep apnea predicts new-onset atrial fibrillation, file e31e124e-bab9-987f-e053-3705fe0a095a
|
105
|
|
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial., file e31e124e-0c71-987f-e053-3705fe0a095a
|
102
|
|
P-wave Variability and Atrial Fibrillation, file e31e124e-1154-987f-e053-3705fe0a095a
|
100
|
|
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes, file e31e124e-070b-987f-e053-3705fe0a095a
|
99
|
|
Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital), file e31e124e-884e-987f-e053-3705fe0a095a
|
98
|
|
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads, file e31e124e-123a-987f-e053-3705fe0a095a
|
97
|
|
Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey, file e31e124f-25b7-987f-e053-3705fe0a095a
|
97
|
|
Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies, file e31e124e-e6bb-987f-e053-3705fe0a095a
|
96
|
|
Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications, file e31e124f-c98e-987f-e053-3705fe0a095a
|
95
|
|
The effects of gender on electrical therapies for the heart: procedural considerations, results and complications: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC), file e31e124e-fbfc-987f-e053-3705fe0a095a
|
94
|
|
Cardiac resynchronization therapy in the real world: need to focus on implant rates, patient selection, co-morbidities, type of devices, and complications, file e31e124f-1207-987f-e053-3705fe0a095a
|
94
|
|
How did COVID-19 affect medical and cardiology journals? A pandemic in literature, file e31e124f-cc40-987f-e053-3705fe0a095a
|
93
|
|
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal, file e31e124d-fb57-987f-e053-3705fe0a095a
|
92
|
|
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC), file e31e124e-acb1-987f-e053-3705fe0a095a
|
91
|
|
Screening for atrial fibrillation: A Report of the AF-SCREEN International Collaboration, file e31e124e-dcb0-987f-e053-3705fe0a095a
|
91
|
|
Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations, file e31e124f-b298-987f-e053-3705fe0a095a
|
90
|
|
Implantable cardioverter-defibrillator–computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study, file e31e124e-e76d-987f-e053-3705fe0a095a
|
89
|
|
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER), file e31e124e-b9e0-987f-e053-3705fe0a095a
|
87
|
|
Oral loading of propafenone: restoring its role before restoring rhythm, file e31e124e-f122-987f-e053-3705fe0a095a
|
85
|
|
Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial, file e31e124f-7bf5-987f-e053-3705fe0a095a
|
85
|
|
Remote monitoring and telemedicine in heart failure: implementation and benefits, file e31e124f-9c85-987f-e053-3705fe0a095a
|
84
|
|
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2, file e31e124f-2331-987f-e053-3705fe0a095a
|
82
|
|
Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy, file e31e124f-424a-987f-e053-3705fe0a095a
|
82
|
|
Integrating new approaches to atrial fibrillation management: The 6th AFNET/EHRA Consensus Conference, file e31e124e-b713-987f-e053-3705fe0a095a
|
81
|
|
Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co-morbidities, file e31e124f-5410-987f-e053-3705fe0a095a
|
75
|
|
Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England, file e31e124f-c20e-987f-e053-3705fe0a095a
|
73
|
|
How to RESPOND to the quest to increase the effectiveness of cardiac resynchronization therapy?, file e31e124e-cf0f-987f-e053-3705fe0a095a
|
72
|
|
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation, file 8ff44ae5-8129-4b12-9dcd-dbc927dcf986
|
71
|
|
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation, file e31e124e-cfc0-987f-e053-3705fe0a095a
|
69
|
|
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology, file e31e1250-6728-987f-e053-3705fe0a095a
|
68
|
|
Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences?, file e31e124f-6960-987f-e053-3705fe0a095a
|
66
|
|
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial, file e31e124f-8243-987f-e053-3705fe0a095a
|
66
|
|
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry, file e31e124f-bb27-987f-e053-3705fe0a095a
|
66
|
|
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE, file e31e124f-2cd3-987f-e053-3705fe0a095a
|
64
|
|
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes, file e31e124f-957e-987f-e053-3705fe0a095a
|
63
|
|
The practice of deep sedation in electrophysiology and cardiac pacing laboratories: Results of an italian survey promoted by the aiac (italian association of arrhythmology and cardiac pacing), file e31e124f-c989-987f-e053-3705fe0a095a
|
63
|
|
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry, file 7af70563-b656-48ab-ae9b-a9a5b584b908
|
62
|
|
Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide, file e31e124f-75f6-987f-e053-3705fe0a095a
|
62
|
|
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy, file e31e124f-7dae-987f-e053-3705fe0a095a
|
61
|
|
Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection, file e31e124f-a085-987f-e053-3705fe0a095a
|
61
|
|
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (Scientific Reports (2016) 6 (30271) DOI: 10.1038/srep30271), file e31e124e-06a9-987f-e053-3705fe0a095a
|
60
|
|
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS), file e31e124f-5435-987f-e053-3705fe0a095a
|
58
|
|
Worldwide Survey of COVID-19 Associated Arrhythmias, file e31e124f-176c-987f-e053-3705fe0a095a
|
57
|
|
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients, file e31e124f-9f99-987f-e053-3705fe0a095a
|
57
|
|
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness, file e31e124f-9580-987f-e053-3705fe0a095a
|
54
|
|
Infective endocarditis with perivalvular abscess complicated by septic embolization with acute ST-segment elevation myocardial infarction and peripheral ischemia, file e31e124f-9dac-987f-e053-3705fe0a095a
|
54
|
|
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis, file 1096c3d1-9ae4-4e57-b9bd-23f73b54ffc9
|
53
|
|
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey, file e31e1250-718b-987f-e053-3705fe0a095a
|
53
|
|
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS, file e31e124f-a18d-987f-e053-3705fe0a095a
|
50
|
| Totale |
12.837 |
